Cargando…

Real-World Data on Chronic Myelomonocytic Leukemia: Clinical and Molecular Characteristics, Treatment, Emerging Drugs, and Patient Outcomes

SIMPLE SUMMARY: Chronic myelomonocytic leukemia (CMML) is an infrequent disease with poor prognosis and risk of progression into acute myeloid leukemia (AML). Stem cell transplantation (alloSCT) is the only potentially curative option. New targeted drugs (NTDs) directed at specific gene mutations ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castaño-Díez, Sandra, López-Guerra, Mónica, Bosch-Castañeda, Cristina, Bataller, Alex, Charry, Paola, Esteban, Daniel, Guijarro, Francesca, Jiménez-Vicente, Carlos, Castillo-Girón, Carlos, Cortes, Albert, Martínez-Roca, Alexandra, Triguero, Ana, Álamo, José Ramón, Beà, Silvia, Costa, Dolors, Colomer, Dolors, Rozman, María, Esteve, Jordi, Díaz-Beyá, Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455040/ https://www.ncbi.nlm.nih.gov/pubmed/36077644 http://dx.doi.org/10.3390/cancers14174107

Ejemplares similares

P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMETHYLATING AGENTS.
por: Jimenez-Vicente, Carlos, et al.
Publicado: (2023)

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome
por: Guijarro, Francesca, et al.
Publicado: (2023)

PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG-TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS
por: Guardia-Torrelles, Ares, et al.
Publicado: (2023)

Novel Tools for Diagnosis and Monitoring of AML
por: Guijarro, Francesca, et al.
Publicado: (2023)

Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing
por: Garrote, Marta, et al.
Publicado: (2023)

P1054: CLINICAL CHARACTERISTICS AND OUTCOMES IN 175 PATIENTS WITH MYELOFIBROSIS ACCORDING TO GENOMIC CLASSIFICATION USING NEXT-GENERATION SEQUENCING
por: Garrote Ordeig, Marta, et al.
Publicado: (2023)

European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
por: Bataller, Alex, et al.
Publicado: (2022)

Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma
por: Nomdedeu, Meritxell, et al.
Publicado: (2015)

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?
por: Magnano, Laura, et al.
Publicado: (2020)

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
por: López-Oreja, Irene, et al.
Publicado: (2023)

Challenges with Approved Targeted Therapies against Recurrent Mutations in CLL: A Place for New Actionable Targets
por: López-Oreja, Irene, et al.
Publicado: (2021)

Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
por: Delgado, Julio, et al.
Publicado: (2020)

Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation
por: Bastidas‐Mora, Gabriela, et al.
Publicado: (2021)

Critical Issues and New Trends on Stat Tests in Clinical Laboratory
por: Arbiol-Roca, Ariadna, et al.
Publicado: (2019)

Survey on Stat Tests in Catalan Clinical Laboratories
por: Arbiol-Roca, Ariadna, et al.
Publicado: (2020)

Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma
por: Rosich, Laia, et al.
Publicado: (2014)

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma
por: Montraveta, Arnau, et al.
Publicado: (2014)

Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survival
por: Geissler, Klaus, et al.
Publicado: (2021)

Reference interval for immature platelet fraction on Sysmex XN haematology analyser in adult population
por: Imperiali, Claudia E., et al.
Publicado: (2018)

Reference intervals for a complete blood count on an automated haematology analyser Sysmex XN in healthy adults from the southern metropolitan area of Barcelona
por: Arbiol-Roca, Ariadna, et al.
Publicado: (2018)

The Genomic Landscape of Juvenile Myelomonocytic Leukemia
por: Stieglitz, Elliot, et al.
Publicado: (2015)

Lysozyme nephropathy in chronic myelomonocytic leukemia
por: Patel, Ami B., et al.
Publicado: (2019)

Diagnosis and treatment of chronic myelomonocytic leukemia
por: Kwon, Jihyun
Publicado: (2021)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report
por: Pelkey, Lauren J, et al.
Publicado: (2022)

Defining an Ultra-Low Risk Group in Asymptomatic IgM Monoclonal Gammopathy
por: Moreno, David F., et al.
Publicado: (2021)

Clinical Lactation Studies of Lithium: A Systematic Review
por: Imaz, Maria Luisa, et al.
Publicado: (2019)

The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia
por: Xargay-Torrent, Sílvia, et al.
Publicado: (2015)

Clinicobiological Characteristics and Outcomes of Patients with T-Cell Large Granular Lymphocytic Leukemia and Chronic Lymphoproliferative Disorder of Natural Killer Cells from a Single Institution
por: Rivero, Andrea, et al.
Publicado: (2021)

Relevance of infections on the outcomes of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia treated with hypomethylating agents: a cohort study from the GESMD
por: Vilorio-Marqués, Laura, et al.
Publicado: (2022)

Unraveling the genetics of transformed splenic marginal zone lymphoma
por: Grau, Marta, et al.
Publicado: (2023)

En torno al Islam y las musulmanas
por: Bramon, Dolors
Publicado: (2010)

Autoedición con WordPerfect 5.1
por: Segarra, Dolors
Publicado: (1992)

Proceso de textos con WordPerfect 5.1
por: Segarra, Dolors
Publicado: (1992)

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy
por: Silkenstedt, Elisabeth, et al.
Publicado: (2019)

Different Population Phenologies of Grapholita molesta (Busck) in Two Hosts and Two Nearby Regions in the NE of Spain
por: Amat, Carles, et al.
Publicado: (2021)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
por: Liu, Xiaoling, et al.
Publicado: (2012)

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
por: Patnaik, M M, et al.
Publicado: (2016)

Fighting back against chronic myelomonocytic leukemia
por: Jo, Deog-Yeon
Publicado: (2013)

Acute Myelomonocytic Leukemia Presenting as Perianal Pain
por: Iqbal, Syma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o835f0htftf2csuqimb839k6u1